Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages

  Sam, Susan ^a   Haffner, Steven ^b   Davidson, Michael H ^c   D'Agostino, Ralph ^d   Perez, Alfonso ^e   Mazzone, Theodore ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d Boston University   (United States)

^e TAKEDA PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTILIPEMIC AGENT; GLIMEPIRIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALIA;

EID: 84855512299     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1699     Document Type: Article

References (13)

1. Kadowaki T, Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocr Rev 26:439-451 (Pubitemid 40686653)
2. Li S, Shin HJ, Ding EL, van Dam RM 2009 Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.JAMA 302:179-188
3. Rasouli N, Kern PA 2008 Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93(Suppl 1):S64-S73
4. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB 2005 Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54:534-539
5. Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D'Agostino Sr RB, Perez A, Provost JC, Haffner SM 2006 Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA 296:2572-2581 (Pubitemid 44903861)
6. Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino Sr R, Kondos GT, Perez A, Chen Z, Mazzone T 2008 Increased highdensity lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Circulation 117:2123-2130 (Pubitemid 351572171)
7. Sam S, Haffner S, Davidson MH, D'Agostino Sr RB, Feinstein S, Kondos G, Perez A, Mazzone T 2008 Relationship of abdominal visceral and subcutaneous adipose tissue to lipoprotein particle number and size in type 2 diabetes. Diabetes 57:2022-2027
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
9. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao YL 2003 Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52:453-462 (Pubitemid 36173203)
10. Weiss R, Otvos JD, Flyvbjerg A, Miserez AR, Frystyk J, Sinnreich R, Kark JD 2009 Adiponectin and lipoprotein particle size. Diabetes Care 32:1317-1319
11. Oku H, Matsuura F, Koseki M, Sandoval JC, Yuasa-Kawase M, Tsubakio-Yamamoto K, Masuda D, Maeda N, Ohama T, Ishigami M, Nishida M, Hirano K, Kihara S, Hori M, Shimomura I, Yamashita S 2007 Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. FEBS Lett 581:5029-5033 (Pubitemid 47576080)
12. Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF 2009 Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men. J Clin Endocrinol Metab 94:989-997
13. Vergès B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F, Gambert P 2006 Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol 26:1364-1369 (Pubitemid 44305383)